Healthcare >> Analyst Interviews >> January 17, 2000
RICHARD A. VAN DEN BROEK is a Managing Director of Research with
Hambrecht & Quist. Prior to joining the firm in 1996, he was associated
with Oppenheimer & Company as a Vice President and Equity Analyst
covering the biotechnology industry. From 1988 to 1991, he researched
viruses under the auspices of Dr. Bernard Fields, the Chairman of the
Microbiology and Molecular Genetics department at Harvard Medical
School. A Chartered Financial Analyst, Mr. van den Broek holds a
Bachelor's degree from Harvard University. Profile
TWST: Tell us how the approach that Hambrecht & Quist takes tobiotechnology differs from that taken by your competitors.
Mr. van den Broek: Most of our traditional competitors have gone